Clinical Trials Browser

Phase 2 × AP 1903 reagent × 30 days × Clear all

NCT07164469 2026-05-06

Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma

Phase 2 Not yet recruiting

Hodgkin Disease